ArticleClinical and translational medicine2026

Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway.

Ying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.